Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: compazine / pepcid / nitroglycerin / dicloxacillin / methylprednisolone / neurontin / bactrim attending: chief complaint: ruq pain major surgical or invasive procedure: placement of port-a-cath central venous access device cholecystectomy history of present illness: pt is a 60 yo female w/ multiple medical problems, who requires long-term narcotic treatment for chronic pain issues, and has been recently treated for a retained stone in the common bile duct/cholangitis, which was relieved by ercp, who now presents with ruq pain. after detailed clinical work-up, she was diagnosed with symptomatic cholelithiasis and scheduled for cholecystectomy and port-a-cath placement for long term central venous administration of narcotics. past medical history: 1. mrsa 2. metastatic thyroid ca s/p iodine and now on synthroid 3. right lower extremity cellulitis 4. nuerogenic bladder- pt self caths. 5. chronic low back pain- pt is on continuous morphine pca. 6. depression 7. type 2 dm 8. chronic arachnoiditis 9. esophageal dysmotility 10. dvt and pe s/p placement of ivc filter 11. chronic utis. 12. osa 13. osteoarthritis 14. chf- last echo was with a lvef of 60%. 15. htn 16. anemia of chronic disease 17. right ankle graft 18. seizure 19. s/p klebsiella line infection 20. s/p ercp for retained stone social history: pt lives with her husband. etoh or tobacco use. not working family history: father - cad, mother - cva physical exam: gen- alert, oriented, obese, no distress heent- perrla, anicteric; no jvd or lad cv- rrr chest- cta bilaterally abd- obese, soft, ttp ruq brief hospital course: as above, pt presented to from a long-term care facility with c/o ruq pain on . recent history of cholangitis. pt afebrile and stable. pt admitted to surgery service. pt on chronic coumadin dose for hx of dvt/pe- started on heparin drip at . ptt would be followed and heparin dose adjusted to achieve ptt between 50 and 70. pt scheduled for cholecystectomy and pre-op completed accordingly. pt underwent open cholecystectomy on . pt tolerated procedure well. after recovery in the , pt was transferreed to the floor in stable condition. pain control would be managed in partnership with the pain service. on pod 2, pt was transferred to the sicu after being found unresponsive, secondary to over-sedation with narcotics. she was administered narcan, narcotics were held, and she quickly regained concsiousness. neurology was consulted to rule-out an intracranial process. a ct scan was obtained which revealed no abnormal findings and she was ruled-out for an intracranial process. she would remain on a narcan drip in the sicu. she was transferred back to the floor on pod 3 in stable condition on a low-dose morphine pca for pain control. she continued to remain stable. she began passin flatus and her diet was advanced to regular on pod 4, which she tolerated well. she was transferred back to her long-term care facility in good condition on pod 7. she will continue to require a heparin drip until her inr is within therapeutic range. she also will remain on a low-dose morphine pca for chronic pain relief. discharge medications: 1. lisinopril 20 mg tablet sig: two (2) tablet po daily (daily). 2. baclofen 10 mg tablet sig: two (2) tablet po tid (3 times a day). 3. docusate sodium 100 mg capsule sig: one (1) capsule po tid (3 times a day). 4. levothyroxine sodium 175 mcg tablet sig: one (1) tablet po bid (2 times a day). 5. nitrofurantoin macrocrystal 100 mg capsule sig: one (1) capsule po qhs (once a day (at bedtime)). 6. levetiracetam 500 mg tablet sig: one (1) tablet po bid (2 times a day). 7. citalopram hydrobromide 20 mg tablet sig: four (4) tablet po daily (daily). 8. insulin regular human 100 unit/ml solution sig: one (1) injection asdir (as directed). 9. trazodone hcl 100 mg tablet sig: one (1) tablet po hs (at bedtime). 10. quinine sulfate 325 mg capsule sig: one (1) capsule po tid (3 times a day). 11. amitriptyline hcl 25 mg tablet sig: two (2) tablet po qhs (once a day (at bedtime)) as needed for anxiety/insomnia. 12. tizanidine hcl 2 mg tablet sig: one (1) tablet po tid (3 times a day). 13. tizanidine hcl 2 mg tablet sig: two (2) tablet po qhs (once a day (at bedtime)). 14. polyethylene glycol 3350 17 g (100%) packet sig: one (1) packet po qhs () as needed for constipation. 15. fleet enema 19-7 g/118ml enema sig: one (1) ml rectal q48 hours () as needed for constipation. 16. magnesium hydroxide 400 mg/5 ml suspension sig: thirty (30) ml po q6h (every 6 hours) as needed. 17. clonidine hcl 0.1 mg/24 hr patch weekly sig: one (1) patch weekly transdermal qsat (every saturday). 18. labetalol hcl 200 mg tablet sig: two (2) tablet po tid (3 times a day). 19. hydralazine hcl 25 mg tablet sig: one (1) tablet po q8h (every 8 hours). 20. warfarin sodium 2 mg tablet sig: one (1) tablet po hs (at bedtime). 21. pantoprazole sodium 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 22. dolasetron mesylate 12.5 mg/0.625 ml solution sig: one (1) intravenous q8h (every 8 hours) as needed for nausea. 23. heparin sod (porcine) in d5w 100 unit/ml parenteral solution sig: 1300 units per hour heparin drip intravenous asdir (as directed): continue until inr is between 2 and 3. please check ptt daily, and ensure that ptt is between 50 and 70 when on heparin drip. 24. heparin flush picc (100 units/ml) 2 ml iv daily:prn 10 ml ns followed by 2 ml of 100 units/ml heparin (200 units heparin) each lumen daily and prn. inspect site every shift. 25. morphine sulfate 10 mg/ml solution sig: pca- 1 mg every 6 minutes. no basal rate. maximum dosage is 10 mg per hour. intravenous once a day: lockout is 1 mg every 6 minutes, with a maximum of 10 mg/hr. no basal rate. discharge disposition: extended care facility: & rehab center - discharge diagnosis: symptomatic cholelithiasis discharge condition: good discharge instructions: please keep wound area clean and dry. take all medications as prescribed. heparin drip should be adjusted to keep ptt between 50 and 70. heparin drip should be dc'd when inr therapeutic (between 2 and 3). inr and ptt should be checked daily until inr is therapeutic and guaranteed to remain therapeutic. followup instructions: please call dr. office at within one week after discharge to schedule a follow-up appointment. procedure: cholecystectomy insertion of totally implantable vascular access device [vad] diagnoses: anemia of other chronic disease congestive heart failure, unspecified toxic encephalopathy unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other convulsions depressive disorder, not elsewhere classified other opiates and related narcotics causing adverse effects in therapeutic use long-term (current) use of other medications long-term (current) use of anticoagulants personal history of venous thrombosis and embolism pressure ulcer, heel lumbago pain in joint, shoulder region chronic cholecystitis personal history of malignant neoplasm of thyroid cervicalgia encounter for therapeutic drug monitoring 

Answer: The patient is high likely exposed to